Motion Medicine
- Manufacturer
- Nutri-Dyn Products Ltd. dba Professional Health Products | Innotech Rehabilitation Products Inc. | International Laboratories (Canada) Ltd.
- Effective date
- 2011-06-20
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 13
- Source
- full-release
- Hydrated at
- 2026-05-31 22:28:21
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active Ingredients (Percent by weight) Purpose
Menthol 4.0% ............................Analgesic (Pain reliever)
Camphor 4.0% ...........................Analgesic (Pain reliever)
INDICATIONS & USAGE SECTION
For the temporary relief of minor aches and pains of muscles and joints associated with simple backache, arthritis, strains, bruises and sprains, etc.
WARNINGS SECTION
Warnings
- Avoid getting into eyes or on mucous membranes.
- If condition worses, or if symptoms persist for more than 7 days or clear up and occur again within a few days, discontinue use of this product and consult a doctor.
- Do not apply to wounds or damaged skin. Do not bandage tightly.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of the reach of children
- Use only as directed.
- If swallowed, get medical help or contact a Poison Control center right away.
DOSAGE & ADMINISTRATION SECTION
Directions
Adults and children 12 years of age or older: Rub this soothing cream on the affected area not more than 3 to 4 times daily.
Children under the age of 12: Do not use, consult a doctor.
INACTIVE INGREDIENT SECTION
C13-14 isoparaffin, caprylyl glycol, cetyl alcohol, chondroitin sulfate, denatured alcohol, eucalyptus oil, glucosamine sulfate, glycerin, grape seed oil, laureth-7, methylsulfonylmethane (MSM), oil of lavender, oil of wintergreen, phenoxyethanol, polyacrylamide, polysorbate-20, sea cucumber extract, sorbic, acid, stearyl alcohol, thymol, urea, vitamin E, water
REFERENCES SECTION
Distributed by:
Motion Medicine Inc.
Suite 258, 132-250 Shawville Blvd. SE
Calgary, AB CANADA T2Y 2Z7
1-866-972-8466
120g
OTC - PURPOSE SECTION
Pain Reliever
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Motion Medicine
Eases pain, improves movement, and is highly effective
Topical Remedy
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 49795-809-05 | 2025-11-13 | C162847 | 48780-1 | 960f7f55-ce06-8e05-e053-dbdaa90a074a | Motion Medicine |
| 49795-809-16 | 2025-11-13 | C162847 | 48780-1 | 960f7f55-ce06-8e05-e053-dbdaa90a074a | Motion Medicine |
| 49795-809-94 | 2025-11-13 | C162847 | 48780-1 | 960f7f55-ce06-8e05-e053-dbdaa90a074a | Motion Medicine |
| 49795-809-05 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-ce06-8e05-e053-dbdaa90a074a | Motion Medicine |
| 49795-809-16 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-ce06-8e05-e053-dbdaa90a074a | Motion Medicine |
| 49795-809-94 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-ce06-8e05-e053-dbdaa90a074a | Motion Medicine |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CAMPHOR (NATURAL) | ACTIVE INGREDIENT | N20HL7Q941 | 13 | |
| Menthol | ACTIVE INGREDIENT | L7T10EIP3A | 13 | |
| CAMPHOR (NATURAL) | ACTIVE MOIETY | N20HL7Q941 | 13 | |
| Menthol | ACTIVE MOIETY | L7T10EIP3A | 13 | |
| C13-14 Isoparaffin | INACTIVE INGREDIENT | E4F12ROE70 | 13 | |
| Caprylyl glycol | INACTIVE INGREDIENT | 00YIU5438U | 13 | |
| Cetyl alcohol | INACTIVE INGREDIENT | 936JST6JCN | 13 | |
| Chondroitin sulfate (bovine) | INACTIVE INGREDIENT | 6IC1M3OG5Z | 13 | |
| Cucumaria Sea Cucumber | INACTIVE INGREDIENT | 3SC3X5I2GC | 13 | |
| Dimethyl sulfone | INACTIVE INGREDIENT | 9H4PO4Z4FT | 13 | |
| Eucalyptus oil | INACTIVE INGREDIENT | 2R04ONI662 | 13 | |
| Glucosamine sulfate | INACTIVE INGREDIENT | 1FW7WLR731 | 13 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 13 | |
| Glycol stearate | INACTIVE INGREDIENT | 0324G66D0E | 13 | |
| Grape Seed Oil | INACTIVE INGREDIENT | 930MLC8XGG | 13 | |
| Lavandula Angustifolia Flower | INACTIVE INGREDIENT | 19AH1RAF4M | 13 | |
| Methyl salicylate | INACTIVE INGREDIENT | LAV5U5022Y | 13 | |
| Phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 13 | |
| Polysorbate 20 | INACTIVE INGREDIENT | 7T1F30V5YH | 13 | |
| Sorbic acid | INACTIVE INGREDIENT | X045WJ989B | 13 | |
| Stearyl alcohol | INACTIVE INGREDIENT | 2KR89I4H1Y | 13 | |
| Thymol | INACTIVE INGREDIENT | 3J50XA376E | 13 | |
| Urea | INACTIVE INGREDIENT | 8W8T17847W | 13 | |
| Vitamin E | INACTIVE INGREDIENT | H4N855PNZ1 | 13 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 13 |
Products#
Every source-derived product name is available through these pages.
- Motion Medicine
- Camphor, Menthol
- CAMPHOR (NATURAL)
- Menthol
- Water
- Cetyl alcohol
- Glycol stearate
- Dimethyl sulfone
- Glycerin
- Stearyl alcohol
- Glucosamine sulfate
- C13-14 Isoparaffin
- Polysorbate 20
- Urea
- Phenoxyethanol
- Caprylyl glycol
- Sorbic acid
- Eucalyptus oil
- Methyl salicylate
- Vitamin E
- Lavandula Angustifolia Flower
- Thymol
- Chondroitin sulfate (bovine)
- Cucumaria Sea Cucumber
- Grape Seed Oil
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 49795-809 | 49795-809-94, 49795-809-05, 49795-809-16 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | TABLET, EXTENDED RELEASE / ORAL | 4.2 mg | ||
| Vitamin E | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | CAPSULE / ORAL | 16 mg | ||
| Sorbic acid | SORBIC ACID | X045WJ989B | TABLET, DELAYED RELEASE / ORAL | 0.03 mg | ||
| Cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | AEROSOL, FOAM / TOPICAL | 84 mg | ||
| Sorbic acid | SORBIC ACID | X045WJ989B | TABLET, COATED / ORAL | 1 mg | ||
| Cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | OINTMENT / TOPICAL | 7 %w/w | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL, FOAM / TOPICAL | 75 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE / ORAL | 3487 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | EMULSION / OPHTHALMIC | 3 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1800 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | ||
| Cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | TABLET, COATED / ORAL | 0.25 mg | ||
| Thymol | THYMOL | 3J50XA376E | LIQUID / RESPIRATORY (INHALATION) | 0.01 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAMUSCULAR | 15 %w/v | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | EMULSION / TOPICAL | 2 %w/w | ||
| Cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | TABLET, FILM COATED / ORAL | NA | ||
| Thymol | THYMOL | 3J50XA376E | POWDER, FOR SOLUTION / ORAL | NA | ||
| Cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | EMULSION / TOPICAL | NA | ||
| Sorbic acid | SORBIC ACID | X045WJ989B | CREAM / TOPICAL | 14 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | CREAM / TOPICAL | 57 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | JELLY / TOPICAL | NA | ||
| Sorbic acid | SORBIC ACID | X045WJ989B | TABLET / SUBLINGUAL | 0.16 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | SPRAY, METERED / NASAL | 40 mg | ||
| Sorbic acid | SORBIC ACID | X045WJ989B | SOLUTION / OPHTHALMIC | 0.2 %w/v | ||
| Vitamin E | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | TABLET / ORAL | 2 mg | ||
| Eucalyptus oil | EUCALYPTUS OIL | 2R04ONI662 | SYRUP / ORAL | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CLOTH / TOPICAL | 0.05 mg/mg | ||
| Cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | CAPSULE, DELAYED RELEASE / ORAL | 59 mg | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | TABLET / ORAL | 17 mg | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | GEL / TOPICAL | 5 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / OPHTHALMIC | 2.5 %w/v | ||
| Vitamin E | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | TABLET, EXTENDED RELEASE / ORAL | 4 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| Cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 59 mg | ||
| Stearyl alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | SUSPENSION / TOPICAL | 201 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| Stearyl alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | TABLET / ORAL | 20 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / NASAL | 25 mg/1ml | ||
| Cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | LOTION / TOPICAL | 1140 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| Urea | UREA | 8W8T17847W | TABLET, EXTENDED RELEASE / ORAL | 0.01 mg | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | SUSPENSION / AURICULAR (OTIC) | 0.1 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / ORAL | 32400 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg | ||
| Sorbic acid | SORBIC ACID | X045WJ989B | EMULSION / OPHTHALMIC | 1 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| Cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | SUSPENSION / OPHTHALMIC | 0.5 %w/v | ||
| Methyl salicylate | METHYL SALICYLATE | LAV5U5022Y | TABLET / ORAL | 10 mg | ||
| Methyl salicylate | METHYL SALICYLATE | LAV5U5022Y | PASTE, DENTIFRICE / DENTAL | 1.1 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / SUBCUTANEOUS | 15 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SUSPENSION / SUBCUTANEOUS | 1.6 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / DENTAL | 15 %w/v |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 43669362-8a9b-53a9-e063-6394a90a5eee | 7a96580e-1123-4d3a-8892-255d4e61fe08 | 2025-11-12 | Warnings | 7a96580e-1123-4d3a-8892-255d4e61fe08 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
